From Today’s Patients to Tomorrow’s Treatments
How can we improve treatment for children with leukaemia while reducing the long-term effects of therapy? For WCMM Clinical Researcher Kees-Jan Pronk, the answers lie in connecting clinical experience with research, from experimental models of blood formation to international clinical trials. Kees-Jan has been affiliated with WCMM Lund since 2017 and is a WCMM Clinical Researcher focusing on Haema
https://www.wcmm.lu.se/article/todays-patients-tomorrows-treatments - 2026-10-02
